LSTALisata Therapeutics, Inc.

$44M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M+22.3% YoY

Gross Profit

$2M12.6% margin

Operating Income

-$58M-321.9% margin

Net Income

-$55M-305.9% margin

EPS (Diluted)

$-251.28

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$51M

Stock-Based Comp.

$11,209

Balance Sheet

Total Assets

$126M

Total Liabilities

$68M

Stockholders' Equity

$59M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$15M	+22.3%
Gross Profit	$2M	$2M	+31.3%
Operating Income	-$58M	-$37M	-56.9%
Net Income	-$55M	-$39M	-40.8%

LSTA FY 2014 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena